IL104086A - Translational activating oligonucleotide sequence useful for the high level expression of polypeptides and a method for producing such polypeptides - Google Patents

Translational activating oligonucleotide sequence useful for the high level expression of polypeptides and a method for producing such polypeptides

Info

Publication number: IL104086A
Authority: IL; Israel
Prior art keywords: plasmid; sequence; dna; fragment; expression vector
Prior art date: 1991-12-18

Application number

IL104086A

Other languages

English (en)

Other versions

IL104086A0 (en

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-12-18

Filing date

1992-12-14

Publication date

1998-03-10

1992-12-14 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1993-05-13 Publication of IL104086A0 publication Critical patent/IL104086A0/xx

1998-03-10 Publication of IL104086A publication Critical patent/IL104086A/en

Links

230000003213 activating effect Effects 0.000 title claims abstract description 76
108091034117 Oligonucleotide Proteins 0.000 title claims abstract description 18
229920001184 polypeptide Polymers 0.000 title claims description 38
102000004196 processed proteins & peptides Human genes 0.000 title claims description 38
108090000765 processed proteins & peptides Proteins 0.000 title claims description 38
238000004519 manufacturing process Methods 0.000 title claims description 10
230000014509 gene expression Effects 0.000 title description 44
108020004511 Recombinant DNA Proteins 0.000 claims abstract description 20
239000013612 plasmid Substances 0.000 claims description 350
238000000034 method Methods 0.000 claims description 41
239000013604 expression vector Substances 0.000 claims description 40
108010076181 Proinsulin Proteins 0.000 claims description 31
230000002103 transcriptional effect Effects 0.000 claims description 23
108091028043 Nucleic acid sequence Proteins 0.000 claims description 16
101000976075 Homo sapiens Insulin Proteins 0.000 claims description 11
PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical group C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 claims description 11
239000002243 precursor Substances 0.000 claims description 11
PESQCPHRXOFIPX-RYUDHWBXSA-N Met-Tyr Chemical group CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PESQCPHRXOFIPX-RYUDHWBXSA-N 0.000 claims description 7
PESQCPHRXOFIPX-UHFFFAOYSA-N N-L-methionyl-L-tyrosine Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 PESQCPHRXOFIPX-UHFFFAOYSA-N 0.000 claims description 7
HGCNKOLVKRAVHD-UHFFFAOYSA-N L-Met-L-Phe Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-UHFFFAOYSA-N 0.000 claims description 4
UASDAHIAHBRZQV-YUMQZZPRSA-N Met-Arg Chemical group CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N UASDAHIAHBRZQV-YUMQZZPRSA-N 0.000 claims description 4
108010068488 methionylphenylalanine Proteins 0.000 claims description 4
HGCNKOLVKRAVHD-RYUDHWBXSA-N Met-Phe Chemical group CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-RYUDHWBXSA-N 0.000 claims description 3
238000012258 culturing Methods 0.000 claims description 2
239000013598 vector Substances 0.000 abstract description 10
239000012634 fragment Substances 0.000 description 98
108020004414 DNA Proteins 0.000 description 78
108090000623 proteins and genes Proteins 0.000 description 56
238000010276 construction Methods 0.000 description 49
210000004027 cell Anatomy 0.000 description 40
239000004098 Tetracycline Substances 0.000 description 31
229960002180 tetracycline Drugs 0.000 description 31
229930101283 tetracycline Natural products 0.000 description 31
235000019364 tetracycline Nutrition 0.000 description 31
150000003522 tetracyclines Chemical class 0.000 description 31
239000000203 mixture Substances 0.000 description 28
102000004169 proteins and genes Human genes 0.000 description 26
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 24
239000000047 product Substances 0.000 description 24
239000000523 sample Substances 0.000 description 23
239000000243 solution Substances 0.000 description 23
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 22
108091008146 restriction endonucleases Proteins 0.000 description 22
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 21
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 20
239000000499 gel Substances 0.000 description 19
108020004999 messenger RNA Proteins 0.000 description 19
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
238000006243 chemical reaction Methods 0.000 description 16
238000002360 preparation method Methods 0.000 description 16
229920001817 Agar Polymers 0.000 description 13
102000053602 DNA Human genes 0.000 description 13
241000588724 Escherichia coli Species 0.000 description 13
239000008272 agar Substances 0.000 description 13
229910001629 magnesium chloride Inorganic materials 0.000 description 12
238000012217 deletion Methods 0.000 description 11
230000037430 deletion Effects 0.000 description 11
238000013507 mapping Methods 0.000 description 11
239000011780 sodium chloride Substances 0.000 description 11
230000009466 transformation Effects 0.000 description 11
101100422644 Caenorhabditis elegans syx-5 gene Proteins 0.000 description 10
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
108020004682 Single-Stranded DNA Proteins 0.000 description 10
230000029087 digestion Effects 0.000 description 10
238000009396 hybridization Methods 0.000 description 10
239000008188 pellet Substances 0.000 description 10
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 9
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 9
229960001484 edetic acid Drugs 0.000 description 9
238000011534 incubation Methods 0.000 description 9
238000011160 research Methods 0.000 description 9
239000006228 supernatant Substances 0.000 description 9
238000013518 transcription Methods 0.000 description 9
230000035897 transcription Effects 0.000 description 9
108091026890 Coding region Proteins 0.000 description 8
108010006025 bovine growth hormone Proteins 0.000 description 8
230000010076 replication Effects 0.000 description 8
229910001868 water Inorganic materials 0.000 description 8
238000005119 centrifugation Methods 0.000 description 7
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 7
238000000605 extraction Methods 0.000 description 7
ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 6
ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 6
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 6
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 6
229960001456 adenosine triphosphate Drugs 0.000 description 6
102000039446 nucleic acids Human genes 0.000 description 6
108020004707 nucleic acids Proteins 0.000 description 6
150000007523 nucleic acids Chemical class 0.000 description 6
238000013519 translation Methods 0.000 description 6
230000014621 translational initiation Effects 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 5
239000000872 buffer Substances 0.000 description 5
230000000694 effects Effects 0.000 description 5
230000001939 inductive effect Effects 0.000 description 5
239000002773 nucleotide Substances 0.000 description 5
125000003729 nucleotide group Chemical group 0.000 description 5
239000001632 sodium acetate Substances 0.000 description 5
235000017281 sodium acetate Nutrition 0.000 description 5
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 5
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
108010061982 DNA Ligases Proteins 0.000 description 4
102000012410 DNA Ligases Human genes 0.000 description 4
JOCBASBOOFNAJA-UHFFFAOYSA-N N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid Chemical compound OCC(CO)(CO)NCCS(O)(=O)=O JOCBASBOOFNAJA-UHFFFAOYSA-N 0.000 description 4
108091081024 Start codon Proteins 0.000 description 4
239000007994 TES buffer Substances 0.000 description 4
238000000246 agarose gel electrophoresis Methods 0.000 description 4
150000001413 amino acids Chemical group 0.000 description 4
AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 4
229960005091 chloramphenicol Drugs 0.000 description 4
WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 4
238000002955 isolation Methods 0.000 description 4
SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
101150078341 rop gene Proteins 0.000 description 4
241000894006 Bacteria Species 0.000 description 3
241001646716 Escherichia coli K-12 Species 0.000 description 3
241000701959 Escherichia virus Lambda Species 0.000 description 3
102000002265 Human Growth Hormone Human genes 0.000 description 3
238000012300 Sequence Analysis Methods 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
239000007984 Tris EDTA buffer Substances 0.000 description 3
239000007983 Tris buffer Substances 0.000 description 3
238000007792 addition Methods 0.000 description 3
239000011543 agarose gel Substances 0.000 description 3
238000013459 approach Methods 0.000 description 3
230000001580 bacterial effect Effects 0.000 description 3
229940041514 candida albicans extract Drugs 0.000 description 3
238000004520 electroporation Methods 0.000 description 3
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 3
229960005542 ethidium bromide Drugs 0.000 description 3
238000010438 heat treatment Methods 0.000 description 3
-1 human growth hormone Proteins 0.000 description 3
239000003550 marker Substances 0.000 description 3
238000002515 oligonucleotide synthesis Methods 0.000 description 3
230000001105 regulatory effect Effects 0.000 description 3
210000003705 ribosome Anatomy 0.000 description 3
230000002269 spontaneous effect Effects 0.000 description 3
239000001226 triphosphate Substances 0.000 description 3
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
239000012137 tryptone Substances 0.000 description 3
238000012795 verification Methods 0.000 description 3
239000012138 yeast extract Substances 0.000 description 3
KMEMIMRPZGDOMG-UHFFFAOYSA-N 2-cyanoethoxyphosphonamidous acid Chemical compound NP(O)OCCC#N KMEMIMRPZGDOMG-UHFFFAOYSA-N 0.000 description 2
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
229930024421 Adenine Natural products 0.000 description 2
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
241000132028 Bellis Species 0.000 description 2
239000002028 Biomass Substances 0.000 description 2
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
108091033380 Coding strand Proteins 0.000 description 2
108020004705 Codon Proteins 0.000 description 2
230000006820 DNA synthesis Effects 0.000 description 2
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
108010016626 Dipeptides Proteins 0.000 description 2
108010000521 Human Growth Hormone Proteins 0.000 description 2
239000000854 Human Growth Hormone Substances 0.000 description 2
102000016943 Muramidase Human genes 0.000 description 2
108010014251 Muramidase Proteins 0.000 description 2
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
108091081021 Sense strand Proteins 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
229960000643 adenine Drugs 0.000 description 2
238000005273 aeration Methods 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
239000001110 calcium chloride Substances 0.000 description 2
229910001628 calcium chloride Inorganic materials 0.000 description 2
235000011148 calcium chloride Nutrition 0.000 description 2
OSQPUMRCKZAIOZ-UHFFFAOYSA-N carbon dioxide;ethanol Chemical compound CCO.O=C=O OSQPUMRCKZAIOZ-UHFFFAOYSA-N 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
230000000295 complement effect Effects 0.000 description 2
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
238000000855 fermentation Methods 0.000 description 2
230000004151 fermentation Effects 0.000 description 2
238000001502 gel electrophoresis Methods 0.000 description 2
230000002608 insulinlike Effects 0.000 description 2
239000004325 lysozyme Substances 0.000 description 2
229960000274 lysozyme Drugs 0.000 description 2
235000010335 lysozyme Nutrition 0.000 description 2
125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 2
238000002156 mixing Methods 0.000 description 2
238000006366 phosphorylation reaction Methods 0.000 description 2
235000011056 potassium acetate Nutrition 0.000 description 2
238000000746 purification Methods 0.000 description 2
238000012552 review Methods 0.000 description 2
229920006395 saturated elastomer Polymers 0.000 description 2
239000007160 ty medium Substances 0.000 description 2
108020004465 16S ribosomal RNA Proteins 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
241000908115 Bolivar Species 0.000 description 1
101000825768 Bos taurus Somatoliberin Proteins 0.000 description 1
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
108091035707 Consensus sequence Proteins 0.000 description 1
238000007399 DNA isolation Methods 0.000 description 1
102100033195 DNA ligase 4 Human genes 0.000 description 1
238000001712 DNA sequencing Methods 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
108700039691 Genetic Promoter Regions Proteins 0.000 description 1
108700007698 Genetic Terminator Regions Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
108010051696 Growth Hormone Proteins 0.000 description 1
102000018997 Growth Hormone Human genes 0.000 description 1
101000927810 Homo sapiens DNA ligase 4 Proteins 0.000 description 1
101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 1
101500025353 Homo sapiens Insulin A chain Proteins 0.000 description 1
101500025354 Homo sapiens Insulin B chain Proteins 0.000 description 1
101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
101001033249 Homo sapiens Interleukin-1 beta Proteins 0.000 description 1
101001002657 Homo sapiens Interleukin-2 Proteins 0.000 description 1
101001033279 Homo sapiens Interleukin-3 Proteins 0.000 description 1
101001002709 Homo sapiens Interleukin-4 Proteins 0.000 description 1
101500025568 Homo sapiens Saposin-D Proteins 0.000 description 1
101000825742 Homo sapiens Somatoliberin Proteins 0.000 description 1
102000003996 Interferon-beta Human genes 0.000 description 1
108090000467 Interferon-beta Proteins 0.000 description 1
102000008070 Interferon-gamma Human genes 0.000 description 1
108010074328 Interferon-gamma Proteins 0.000 description 1
108010063738 Interleukins Proteins 0.000 description 1
102000015696 Interleukins Human genes 0.000 description 1
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical class CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
241000364057 Peoria Species 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 1
239000004353 Polyethylene glycol 8000 Substances 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
239000004365 Protease Substances 0.000 description 1
108010094028 Prothrombin Proteins 0.000 description 1
102000009661 Repressor Proteins Human genes 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
108700005078 Synthetic Genes Proteins 0.000 description 1
108020005038 Terminator Codon Proteins 0.000 description 1
101710099760 Tetracycline resistance protein Proteins 0.000 description 1
108091036066 Three prime untranslated region Proteins 0.000 description 1
102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
241000700605 Viruses Species 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
229960000583 acetic acid Drugs 0.000 description 1
230000004913 activation Effects 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
238000010804 cDNA synthesis Methods 0.000 description 1
235000011089 carbon dioxide Nutrition 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
239000013599 cloning vector Substances 0.000 description 1
AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
238000011033 desalting Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
238000009585 enzyme analysis Methods 0.000 description 1
239000000284 extract Substances 0.000 description 1
238000012262 fermentative production Methods 0.000 description 1
230000008014 freezing Effects 0.000 description 1
238000007710 freezing Methods 0.000 description 1
229940044627 gamma-interferon Drugs 0.000 description 1
239000012362 glacial acetic acid Substances 0.000 description 1
239000008103 glucose Substances 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
102000055277 human IL2 Human genes 0.000 description 1
102000055229 human IL4 Human genes 0.000 description 1
229940100689 human protein c Drugs 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
230000003993 interaction Effects 0.000 description 1
229940079322 interferon Drugs 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000012160 loading buffer Substances 0.000 description 1
230000002934 lysing effect Effects 0.000 description 1
238000005259 measurement Methods 0.000 description 1
239000002609 medium Substances 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
NCGWKCHAJOUDHQ-UHFFFAOYSA-N n,n-diethylethanamine;formic acid Chemical compound OC=O.OC=O.CCN(CC)CC NCGWKCHAJOUDHQ-UHFFFAOYSA-N 0.000 description 1
108010083127 phage repressor proteins Proteins 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
238000013492 plasmid preparation Methods 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
229940085678 polyethylene glycol 8000 Drugs 0.000 description 1
235000019446 polyethylene glycol 8000 Nutrition 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000011591 potassium Substances 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
230000001376 precipitating effect Effects 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
108010066381 preproinsulin Proteins 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
230000017854 proteolysis Effects 0.000 description 1
239000011535 reaction buffer Substances 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
239000007787 solid Substances 0.000 description 1
241000894007 species Species 0.000 description 1
239000000126 substance Substances 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
229960000187 tissue plasminogen activator Drugs 0.000 description 1
230000005030 transcription termination Effects 0.000 description 1
229940035893 uracil Drugs 0.000 description 1
229960005356 urokinase Drugs 0.000 description 1
238000003260 vortexing Methods 0.000 description 1
239000008096 xylene Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/73—Expression systems using phage (lambda) regulatory sequences

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
Virology (AREA)
Plant Pathology (AREA)
Endocrinology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Enzymes And Modification Thereof (AREA)
Programmable Controllers (AREA)
Peptides Or Proteins (AREA)

IL104086A 1991-12-18 1992-12-14 Translational activating oligonucleotide sequence useful for the high level expression of polypeptides and a method for producing such polypeptides IL104086A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US81104591A	1991-12-18	1991-12-18

Publications (2)

Publication Number	Publication Date
IL104086A0 IL104086A0 (en)	1993-05-13
IL104086A true IL104086A (en)	1998-03-10

Family

ID=25205390

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL104086A IL104086A (en)	1991-12-18	1992-12-14	Translational activating oligonucleotide sequence useful for the high level expression of polypeptides and a method for producing such polypeptides

Country Status (12)

Country	Link
EP (1)	EP0547873B1 (de)
JP (1)	JPH05276950A (de)
AT (1)	ATE157122T1 (de)
AU (1)	AU663139B2 (de)
CA (1)	CA2085447A1 (de)
DE (1)	DE69221708T2 (de)
DK (1)	DK0547873T3 (de)
ES (1)	ES2104856T3 (de)
GR (1)	GR3024762T3 (de)
HU (1)	HU218269B (de)
IL (1)	IL104086A (de)
MX (1)	MX9207265A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT500850B1 (de) *	2000-12-26	2007-10-15	Monsanto Technology Llc	Rekombinante dna-vektoren zur expression von somatotropinen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5126249A (en) *	1989-05-09	1992-06-30	Eli Lilly And Company	Enzymatic removal of a protein amino-terminal sequence
IL99100A0 (en) *	1990-08-13	1992-07-15	Lilly Co Eli	Improved bacteriophage lambda pl promoters

1992
- 1992-12-14 IL IL104086A patent/IL104086A/en not_active IP Right Cessation
- 1992-12-15 ES ES92311446T patent/ES2104856T3/es not_active Expired - Lifetime
- 1992-12-15 AT AT92311446T patent/ATE157122T1/de not_active IP Right Cessation
- 1992-12-15 CA CA002085447A patent/CA2085447A1/en not_active Abandoned
- 1992-12-15 DK DK92311446.6T patent/DK0547873T3/da active
- 1992-12-15 DE DE69221708T patent/DE69221708T2/de not_active Expired - Fee Related
- 1992-12-15 EP EP92311446A patent/EP0547873B1/de not_active Expired - Lifetime
- 1992-12-15 MX MX9207265A patent/MX9207265A/es not_active IP Right Cessation
- 1992-12-16 AU AU30195/92A patent/AU663139B2/en not_active Ceased
- 1992-12-16 HU HU9203981A patent/HU218269B/hu not_active IP Right Cessation
- 1992-12-17 JP JP4337249A patent/JPH05276950A/ja active Pending
1997
- 1997-09-17 GR GR970402417T patent/GR3024762T3/el unknown

Also Published As

Publication number	Publication date
IL104086A0 (en)	1993-05-13
HU9203981D0 (en)	1993-04-28
GR3024762T3 (en)	1997-12-31
MX9207265A (es)	1993-07-01
EP0547873B1 (de)	1997-08-20
ATE157122T1 (de)	1997-09-15
EP0547873A2 (de)	1993-06-23
JPH05276950A (ja)	1993-10-26
DK0547873T3 (da)	1997-09-15
CA2085447A1 (en)	1993-06-19
HU218269B (hu)	2000-06-28
AU663139B2 (en)	1995-09-28
DE69221708T2 (de)	1998-01-22
AU3019592A (en)	1993-06-24
HUT65816A (en)	1994-07-28
ES2104856T3 (es)	1997-10-16
EP0547873A3 (de)	1994-08-31
DE69221708D1 (de)	1997-09-25

Legal Events

Date	Code	Title
1998-09-24	FF	Patent granted
1998-12-27	KB	Patent renewed
2003-02-12	KB	Patent renewed
2007-08-19	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
EP0095361B1 (de)	1989-07-26	Klonbildungsvektoren für die Expression von exogenem Protein
US4795706A (en)	1989-01-03	Novel expression control sequences
AU698656B2 (en)	1998-11-05	Promoters for gene expression
US5192669A (en)	1993-03-09	Method to produce recombinant proteins using an expression vector comprising transcriptional and translational activating sequences
EP0195303A1 (de)	1986-09-24	Plasmidvektoren zur Expression in Escherichia coli und/oder Bacillus subtilis
US5063158A (en)	1991-11-05	Recombinant DNA expression vector comprising both transcriptional and translational activating sequences
EP1185675B1 (de)	2005-11-30	Den menschlichen granulozyten-kolonie-stimulierenden faktor (g-csf) auscheidender escherichia coli stamm
EP0063494A2 (de)	1982-10-27	Verfahren zum Produzieren von Protein aus einem Mikroorganismus, Mikroorganismen zur Verwendung in solchem Verfahren und ihre Erzeugung, Vektoren zur Verwendung in dieser Erzeugung und Protein produziert durch diesen Mikroorganismus und von diesen Mikroorganismen abgeleitete transformierte Kulturen
EP0134673B1 (de)	1991-10-09	Plasmidvektor und seine Verwendung
US4772555A (en)	1988-09-20	Dedicated ribosomes and their use
EP0159123B1 (de)	1992-01-15	Expressionsvektoren für Rinderwachstumshormonderivate
KR100393297B1 (ko)	2004-10-20	돌연변이체aox2프로모터,이를보유한벡터,형질전환체및이종단백질의제조방법
EP0547873B1 (de)	1997-08-20	Neue Translationsaktivierungssequenz
CA1283374C (en)	1991-04-23	Recombinant dna expression vectors and method for gene expression
US5395761A (en)	1995-03-07	Plasmid pHKY334, an expression vector for EK-BGH and host cells transformed therewith
EP0493926A1 (de)	1992-07-08	Verfahren zur Erhöhung der strukturellen Stabilität von rekombinanten DNS-Expressionsvektoren
EP0471514A2 (de)	1992-02-19	Verbesserte Bakteriophage-lambda-pL-Promotoren
US5576190A (en)	1996-11-19	Bacteriophage Lambda pL promoters
EP0316115A2 (de)	1989-05-17	Vektoren und Expressionssequenzen zur Herstellung von Polypeptiden
JPH01132383A (ja)	1989-05-24	プラスミド組換え体
HK1004148B (en)	2004-01-30	Promoters for gene expression